EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Leveraging Quantitative Proteomics and Extracellular Vesicle Data to Uncover Druggable Receptor Kinases Across Cancers

Jina Kim iD, Su Yeon Yeon, Kyerim Choi, Hojung Kim, Hyoyoung Kim, Daehee Hwang, Sungyong You

Journal of Extracellular Vesicles · 2026-04 · 15 (4)

DOI: 10.1002/jev2.70275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 14.04.2026. Verfasst von Jina Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Cedars-Sinai Medical Center, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, Proteomics, Neoplasms, Receptor Protein-Tyrosine Kinases. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) play an important role in cancer progression and metastasis. The increasing clinical proteomics data provides an opportunity to uncover new biomarkers and therapeutic targets in cancer specific EVs. Here, we present an integrated data analysis approach that leverages a comprehensive protein catalog from EVs, blood plasma, and the cancer cell surface to identify EV‐associated proteins and evaluate their potential as therapeutic targets in cancer cells. Quantitative proteomics data from 12 cancer types ( n = 2,272) identified 3,250 proteins that are commonly found in EV studies and EV quantity data. Receptor kinases (RKs) are crucial in cancer signalling pathways and have been widely studied targets. Our analysis focused on identifying RKs with significant high expression in cancer types that were also detected in EVs. Notably, PTK7 emerged as a significant target with high expression or survival association in seven independent cancer cohorts. We then explored the druggability of the RKs. Our analysis of drug repurposing network and RNAi screening suggested PTK7 as a potential therapeutic target with no FDA approved drugs in cancer. Overall, this integrative analysis proposes a framework to prioritize EV‐associated candidates for downstream therapeutic investigation in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesProteomicsNeoplasmsReceptor Protein-Tyrosine KinasesHumansBiomarkers, TumorCell Adhesion MoleculesSignal Transduction

Stichwörter der Autor:innen

extracellular vesiclespan‐cancerproteomicsreceptor kinasestherapeutic targets

Substanzen

PTK7 protein, humanReceptor Protein-Tyrosine KinasesBiomarkers, TumorCell Adhesion Molecules

Autor:innen und Institutionen

  • Department of Urology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Department of Pathology, University of Illinois Chicago, Chicago, Illinois, USA.
  • School of Biological Sciences, Seoul National University, Seoul, Republic of Korea.
  • Samuel-Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.

ORCID-Profile: Jina Kim

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Kim, J., Yeon, S. Y., Choi, K., Kim, H., Kim, H., Hwang, D., & You, S. (2026). Leveraging Quantitative Proteomics and Extracellular Vesicle Data to Uncover Druggable Receptor Kinases Across Cancers. Journal of Extracellular Vesicles, 15(4). https://doi.org/10.1002/jev2.70275

Vancouver

Kim J, Yeon SY, Choi K, Kim H, Kim H, Hwang D, et al. Leveraging Quantitative Proteomics and Extracellular Vesicle Data to Uncover Druggable Receptor Kinases Across Cancers. Journal of Extracellular Vesicles. 2026;15(4). doi:10.1002/jev2.70275

BibTeX
@article{Kim2026,
  author = {Kim, Jina and Yeon, Su Yeon and Choi, Kyerim and Kim, Hojung and Kim, Hyoyoung and Hwang, Daehee and You, Sungyong},
  title = {Leveraging Quantitative Proteomics and Extracellular Vesicle Data to Uncover Druggable Receptor Kinases Across Cancers},
  journal = {Journal of Extracellular Vesicles},
  year = {2026},
  volume = {15},
  number = {4},
  doi = {10.1002/jev2.70275}
}
Kostenlos starten →